a developer of novel treatments for inherited and acquired genetic disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To MGTX | 1D Price Change % | ||
---|---|---|---|---|
MGTX | 100% | +5.71% | ||
NTLA - MGTX | 52% Loosely correlated | -3.24% | ||
BEAM - MGTX | 51% Loosely correlated | -1.57% | ||
EDIT - MGTX | 50% Loosely correlated | -3.58% | ||
ABOS - MGTX | 48% Loosely correlated | -5.42% | ||
QSI - MGTX | 47% Loosely correlated | +2.06% | ||
More |
Ticker / NAME | Correlation To MGTX | 1D Price Change % |
---|---|---|
MGTX | 100% | +5.71% |
drugs theme (254 stocks) | 52% Loosely correlated | -1.72% |
cancer theme (82 stocks) | 51% Loosely correlated | -2.38% |
diseases theme (41 stocks) | 46% Loosely correlated | -1.18% |
biotechnology theme (238 stocks) | 37% Loosely correlated | -1.80% |
novel medical theme (11 stocks) | 34% Loosely correlated | +0.29% |